Jeffrey S. Hackman - 16 May 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 May 2025, 17:42:21 UTC
Prior SEC filing
03 Apr 2025
Next SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeff Hackman

Key filing fact

Jeffrey S. Hackman filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 19 May 2025.

Key facts

  • This page summarizes Jeffrey S. Hackman's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2025, 17:42.

Change

  • Previous filing in this sequence was filed on 03 Apr 2025.
  • Current net transaction value: +$104,602.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001926254 Primary reporting owner

Hackman Jeffrey S.

Relationship
Chief Executive Officer, Director
Address
68 TW ALEXANDER DRIVE, PO BOX 13628, RESEARCH TRIANGLE PARK
Signature
/s/ Jeff Hackman
Signature date
19 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FENC transaction

Common Shares

Purchase

Transaction value
$6,986
Shares
+1,035
Change %
Price
$6.75
Shares after
1,035
Date
16 May 2025
Ownership
Direct
Footnotes
F1
FENC transaction

Common Shares

Purchase

Transaction value
$97,615
Shares
+13,965
Change %
+1349%
Price
$6.99
Shares after
15,000
Date
19 May 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Transaction Code P - Open market or private purchase of non-derivative or derivative security

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .